• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » InVivo Therapeutics settles monkey business with Oregon research facility

InVivo Therapeutics settles monkey business with Oregon research facility

January 4, 2010 By MassDevice staff

Attorneys for InVivo Therapeutics Inc. said the company has settled a lawsuit it filed against an Oregon research facility after a botched primate study last year.

Alexander Furey, the attorney for the Cambridge, Mass.-based tissue regeneration developer, told MassDevice that InVivo and Oregon Health & Sciences University reached a settlement. Furey declined to provide any specifics on the terms of the agreement, saying only that “the settlement was confidential.”

InVivo, an early-stage medical device company that’s working on treatments for severe spinal cord injuries using implantable polymers, filed suit against OHSU in the U.S. District Court for Massachusetts in September, 2009. The company accused OHSU of breach of contract, breach of good faith, fraud, fraudulent inducement, misrepresentation, unjust enrichment and unfair business practices.

InVivo contended that the research facility failed to provide the agreed-upon number of primates for a second primate study and that complications following surgery to sever the monkeys’ spinal cords, which led to the euthanization of four of the primates, were due to negligence on OHSU’s part. The failed study cost InVivo more than $500,000 and significantly derailed its plans, according to the company.

OHSU, which vigorously denied all of InVivo’s claims, in a statement jointly issued with InVivo, said “the individuals who conducted the research and cared for the animals acted professionally, ethically and with the utmost concern for the humane treatment of the animals.”

InVivo has since resumed primate studies at St. Kitts Biomedical Research Facility in the U.S. Virgin Islands, the site of its initial primate study in 2007. The company also filed for an investigational device exemption from the Food & Drug Administration in December, 2009, seeking to conduct human trials.

Filed Under: Business/Financial News, News Well, Spine Tagged With: Tissue Regeneration

More recent news

  • China reportedly launches country’s first invasive BCI trial
  • Neuralink files to raise $649M in new equity offering
  • BofA: Surgical robot remanufacturing not a major setback for Intuitive
  • InspireMD wins CE Mark approval for CGuard Prime
  • Philips reports first cases for VeriSight Pro 3D ICE catheter in Europe

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy